Press Releases

Apr 20, 2026

Jordan Park

Press Releases

Prelude Therapeutics Presents Preclinical Data from Development Candidate, PRT13722, a First-in-Class, Orally Bioavailable, Potent and Highly Selective KAT6A Degrader at American Association for Cancer Research (AACR) Annual Meeting 2026

Prelude Therapeutics presented preclinical data demonstrating that PRT13722, a novel, orally bioavailable, and highly selective KAT6A degrader, shows potent efficacy and an improved safety profile in multiple models of hormone receptor positive, HER2-negative breast cancer. The data suggest enhanced tumor regression and potential for combination th…

PRLD

Apr 20, 2026

Marcus Reed

Press Releases

Oculis Announces Completion of Last Patient Visit in Phase 3 DIAMOND Program with OCS-01 Eye Drops for the Treatment of Diabetic Macular Edema

Oculis Holding AG has announced the completion of the last patient visits in its Phase 3 DIAMOND program evaluating OCS-01, a novel non-invasive topical eye drop treatment for diabetic macular edema (DME). The program includes over 800 patients across two pivotal trials. Topline results are expected in June 2026, with potential NDA submission later…

OCS

Apr 20, 2026

Nina Shah

Press Releases

Niu Technologies to Report First Quarter 2026 Financial Results on May 18, 2026

Niu Technologies, a leading smart urban mobility company, will report its first quarter 2026 financial results on May 18, 2026, before the U.S. market opens. The company will hold an earnings conference call to discuss the financial and business outcomes. NIU designs and sells electric motorcycles, mopeds, bicycles, scooters, and e-bikes through an…

NIU

Apr 20, 2026

Derek Hwang

Press Releases

Supplemental Update Regarding the Board’s Current Pricing Approach for Future M&A-Related Share Issuances

Allied Gaming & Entertainment Inc. announced that its Board of Directors has established a disciplined pricing approach for future equity issuances in M&A transactions, setting a reference floor price of $2.00 per share, reflecting the company's asset base and platform value. This approach aims to protect existing shareholders amid ongoing strategi…

AGAE

Apr 20, 2026

Leila Farooq

Press Releases

Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology

Nanobiotix announced promising preclinical data demonstrating that its Nanoprimer platform, when used prior to lipid nanoparticle-delivered recombinant DNA immunotherapy, increases systemic bioavailability, reduces liver toxicity, and mitigates inflammatory responses in a mouse model. These findings support further development of Nanoprimer as a th…

NBTX

Apr 20, 2026

Leila Farooq

Press Releases

Diversified Energy TR-1

Barclays PLC has submitted a TR-1 notification regarding its holdings in Diversified Energy Company, indicating that its total voting rights have fallen below the notifiable threshold. The notification details changes in voting rights ownership and confirms that no major changes surpassing disclosure requirements have occurred.

DECC

Apr 20, 2026

Jordan Park

Press Releases

Tencent Invests in Kaspi.kz Alongside Co-Founder & CEO Mikheil Lomtadze and Long-Term U.S. Institutional Investors

Kaspi.kz, a leading fintech and super app operator in Kazakhstan and Türkiye, announced a strategic investment by Tencent, Kaspi.kz's Co-Founder and CEO Mikheil Lomtadze, senior management, and US institutional investors acquiring 6 million ADSs from existing shareholders, strengthening the company's capital base as it expands its market leadership…

KSPI

Apr 19, 2026

Jordan Park

Press Releases

B2Gold Reports Update on Fire-Related Incident to the Crushing Circuit at the Goose Mine

B2Gold Corp. announced an update on a fire incident at the crushing circuit of its Goose Mine. The fire caused localized damage, with no injuries reported. The company has deployed mobile crushers and plans additional temporary crushing capacity to maintain ore processing. Repairs are expected to conclude by Q3 2026, with the crushing circuit's cap…

BTO

Apr 19, 2026

Maya Rios

Press Releases

Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day

Fiserv, Inc. will release its first quarter 2026 earnings results on May 5 before market open, followed by a webcast presentation. Furthermore, the company will hold an Investor Day on May 14 to detail its business strategy and medium-term outlook. Both events will be accessible via live webcast on the company's investor relations website.

FISV

Apr 19, 2026

Ajmal Hussain

Press Releases

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

Ascendis Pharma A/S has begun trading its ordinary shares on the Nasdaq Global Select Market under ticker ASND, replacing its previous American Depositary Shares (ADSs) listing. This follows a mandatory exchange of all outstanding ADSs for ordinary shares, completed on April 20, 2026.

ASND

Apr 19, 2026

Ajmal Hussain

Press Releases

Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth

Commerce's BigCommerce platform has powered Mountain Warehouse's launch of a new composable ecommerce store, replacing their decade-old system. This upgrade allows Mountain Warehouse to scale more efficiently, accelerate innovation, and improve global ecommerce operations, leveraging a flexible, modern tech stack with enhanced security and integrat…

CMRC

Apr 19, 2026

Ajmal Hussain

Press Releases

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

Ardelyx, Inc., a Nasdaq-listed biopharmaceutical firm, announces the appointment of Felecia W. Ettenberg as Chief Legal Officer. Ms. Ettenberg brings over 25 years of legal expertise in the biopharmaceutical industry, most recently from Bristol Myers Squibb. She will lead Ardelyx's legal, compliance, regulatory, and government affairs functions, po…

ARDX

Apr 19, 2026

Priya Menon

Press Releases

Astec Names Chad Hartley Group President

Astec Industries, a Nasdaq-listed manufacturer specializing in equipment for road building and aggregate processing, announced the appointment of Chad Hartley as Group President of Infrastructure Solutions. Hartley brings extensive leadership experience from Regal Rexnord and Emerson Electric, and is expected to drive operational improvements and c…

ASTE

Apr 19, 2026

Maya Rios

Press Releases

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

Fulcrum Therapeutics, a clinical-stage biopharmaceutical company focused on rare hematological disorders, will release its Q1 2026 financial results on April 27, 2026, prior to market open. Management will hold a conference call and webcast at 8:00 a.m. ET to discuss the results and corporate updates, including progress on their lead program, pocir…

FULC

Apr 19, 2026

Jordan Park

Press Releases

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

Amneal Pharmaceuticals announced encouraging interim data from its ongoing Phase 4 ELEVATE-PD study evaluating CREXONT®, an extended-release carbidopa/levodopa formulation for Parkinson's disease. Among 111 patients switching from existing therapies such as IR CD/LD and RYTARY®, CREXONT significantly increased daily 'Good On' time by approximately …

AMRX

Apr 19, 2026

Derek Hwang

Press Releases

Abacus Global Management to Participate in the 2026 Milken Institute Global Conference

Abacus Global Management, a NYSE-listed alternative asset management company, announced its participation in the 2026 Milken Institute Global Conference. The company's CEO will discuss key trends impacting private wealth, including aging populations, the great wealth transfer, and AI's role in financial advice. Abacus management will also engage in…

ABX

Apr 19, 2026

Priya Menon

Press Releases

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

Phathom Pharmaceuticals announced it will report its Q1 2026 financial results and provide a business update via a live webcast on April 30, 2026. The company focuses on developing and commercializing novel gastrointestinal disease treatments, including its marketed product VOQUEZNA for GERD and H. pylori infection treatment in the U.S.

PHAT

Apr 19, 2026

Sofia Navarro

Press Releases

LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom

LENZ Therapeutics has submitted a Marketing Authorization Application to the UK's MHRA for VIZZ®, an FDA-approved aceclidine-based eye drop for presbyopia treatment. This marks the sixth regulatory submission outside the US as LENZ advances international commercialization efforts following positive Phase 3 trial results and early US market launch.

LENZ

Apr 19, 2026

Sofia Navarro

Press Releases

Beyond Cancer Reports Updated Survival and Safety Data from Phase 1 UNO Trial Presented at AACR 2026

Beyond Air's subsidiary, Beyond Cancer, presented updated Phase 1 clinical data for its investigational immunotherapy UNO at AACR 2026, reporting prolonged survival in heavily pretreated cancer patients after a single intratumoral injection. The trial included patients with breast cancer, squamous cell carcinoma, and melanoma, many of whom had exha…

XAIR

Apr 19, 2026

Marcus Reed

Press Releases

Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026

Allogene Therapeutics presented new scientific data and advancements at the AACR 2026 Annual Meeting, emphasizing the potential of their allogeneic CAR T cell therapies to provide off-the-shelf, scalable, and accessible treatment options for cancer and autoimmune diseases. The company showcased dual-targeting technology and expanded their pipeline,…

ALLO

Apr 19, 2026

Hana Yamamoto

Press Releases

Fortuna Establishes Presence in the Guyana Shield Through Quartzstone Earn-In Agreement

Fortuna Mining Corp., a Canadian precious metals miner listed on the NYSE and TSX, has entered into an earn-in agreement with Qstone Inc. to acquire up to a 70% interest in the Quartzstone Project, a 29,600-hectare land package in Guyana's highly prospective gold-rich greenstone belt. Historical drilling reveals multiple zones of high-grade near-su…

FSM

Apr 19, 2026

Priya Menon

Press Releases

BlackRock® Canada Announces April Cash Distributions for the iShares® ETFs

BlackRock Asset Management Canada, a subsidiary of BlackRock, Inc., announced the cash distributions payable in April 2026 for various iShares exchange-traded funds listed on the TSX and Cboe Canada, including both bond and equity ETFs. The distributions apply to unitholders of record as of April 27, 2026, with payments on April 30, 2026. Distribut…

BLK

Apr 19, 2026

Priya Menon

Press Releases

Silvaco Partners with ITRI to Support MCU Development and Startup Innovation

Silvaco Group, Inc. announced a strategic partnership with Taiwan's Industrial Technology Research Institute (ITRI) to deploy Silvaco's SmartSpice circuit simulation solution within ITRI's Nankang IC Design Incubation Center. This collaboration aims to support advanced microcontroller unit (MCU) development and accelerate startup innovation in semi…

SVCO

Apr 19, 2026

Avery Klein

Press Releases

Super League Issues Letter Encouraging Shareholders to Vote in Support of the Misfits Ads Division Acquisition

Super League Enterprise, Inc. announced a shareholder letter encouraging support for its acquisition of the Misfits Ads Division. The acquisition is expected to add profitable revenue, improve financial predictability, expand market share, and speed the company's path to sustainable cash-based EBITDA profitability. The transaction diversifies reven…

SLE

Apr 19, 2026

Nina Shah

Press Releases

Immuneering Presents Genetic Data at AACR Annual Meeting Demonstrating Mechanism to Improve Durability and Survival, Supporting Use of Atebimetinib in First-Line Pancreatic Cancer and Beyond

Immuneering Corporation presented new genetic data at the AACR Annual Meeting demonstrating that their MEK inhibitor, atebimetinib, rarely induces common resistance mutations in the MAPK pathway in treated patients. This supports the drug's potential for durable tumor shrinkage and improved survival in first-line pancreatic cancer. The company is a…

IMRX